ARG83054

Human SARS-CoV-2 IgA antibody ELISA Kit

Datasheet

订购信息

包装

价格 (USD)

96 wells

599

arigo in CHINA:
恩瑞科生物
☎ 400-886-0853,
0571-8708-1890

概述

产品描述	ARG83054 Human SARS-CoV-2 IgA antibody ELISA Kit is an enzyme immunoassay kit for the qualitative of SARS-CoV-2 IgA antibody in Human serum and plasma (EDTA, heparin, citrate)
反应物种	Hu
应用	ELISA
靶点名称	Human SARS-CoV-2 IgA
偶联标记	HRP
偶联标记说明	Substrate: TMB and read at 450 nm.
灵敏度	diagn. 100 %
检测范围	Cut - off
样品类型	serum, plasma (citrate, heparin)
样本量	100 µl
精确	Intra-Assay CV: less than 8% Inter-Assay CV: less than 7%
別名	SARS-CoV

应用说明

检测时间	~2 hour

属性

形式	96 well
存放说明	Store the kit at 2-8°C. Keep microplate wells sealed in a dry bag with desiccants. Do not expose test reagents to heat, sun or strong light during storage and usage. Please refer to the product user manual for detail temperatures of the components.
注意事项	For laboratory research only, not for drug, diagnostic or other use.

生物信息

背景介绍	Severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) is a strain of coronavirus that causes COVID-19 (coronavirus disease 2019), the respiratory illness responsible for the ongoing COVID-19 pandemic. The virus previously had a provisional name, 2019 novel coronavirus (2019-nCoV), and has also been called the human coronavirus 2019 (HCoV-19 or hCoV-19). First identified in the city of Wuhan, Hubei, China, the World Health Organization declared the outbreak a public health emergency of international concern on January 30, 2020, and a pandemic on March 11, 2020. SARS‑CoV‑2 is a positive-sense single-stranded RNA virus that is contagious in humans.
产品亮点	Related products: SARS-CoV antibodies; SARS-CoV ELISA Kits; SARS-CoV recombinant proteins; Anti-Human IgG secondary antibodies; Related news: HMGB1, a biomarker and therapeutic target in COVID-19 Exploring Antiviral Immune Response

背景介绍

Severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) is a strain of coronavirus that causes COVID-19 (coronavirus disease 2019), the respiratory illness responsible for the ongoing COVID-19 pandemic. The virus previously had a provisional name, 2019 novel coronavirus (2019-nCoV), and has also been called the human coronavirus 2019 (HCoV-19 or hCoV-19). First identified in the city of Wuhan, Hubei, China, the World Health Organization declared the outbreak a public health emergency of international concern on January 30, 2020, and a pandemic on March 11, 2020. SARS‑CoV‑2 is a positive-sense single-stranded RNA virus that is contagious in humans.

产品亮点